Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up

Illumina urges shareholders to reject Carl Icahn’s board nominees as proxy fight heats up

Source: 
CNBC
snippet: 
  • Illumina urged shareholders to reject Carl Icahn’s three board nominees at the next annual meeting.
  • The DNA-sequencing company said in a preliminary proxy statement that Carl Icahn’s board nominees would “threaten the progress” of its core business.
  • Illumina’s remarks are its latest move in a brewing proxy fight with Icahn, who owns a 1.4% stake in the company.